
Anthony C. Forster
Professor / University Chair in Chemical Biology
Uppsala University
Sweden
Biography
Anthony C. Forster (Ph.D. Biochem., U. Adelaide; M.D., Harvard U.) researches RNA, protein synthesis and applications thereof (synthetic biology). He discovered the hammerhead catalytic RNA structure, invented external guide sequences for ribonuclease P, and created unnatural genetic codes de novo, all of which founded biotech companies. He has published in journals including Cell, Nature and Science, edited volumes of Methods and Biotechnology J., and coauthored "Synthetic Biology: A Lab Manual."
Research Interest
Synthetic biology, protein synthesis and drug discovery SynBio is a creative new field defined as the complex engineering of replicating systems. It encompasses next-generation technology for bioengineering and fresh approaches to global challenges such as drug discovery and biofuels. Our current projects include: 1. Improving ribosomal incorporation of unnatural amino acids for investigating translation mechanism and for applications such as directed evolution of peptidomimetic drugs. 2. Metagenomic discovery of antibiotic resistance genes in humans, and overcoming resistance by antisense bacteriophage therapy. 3. Development of chromoproteins for biosensor diagnostics. 4. Simplifying the design and assembly of large genetic pathways and systems. 5. Determining functions of ribosomal RNA modifications towards synthesis of the ribosome, self-replication and a minimal cell.
Biography
Mr. Arata Katayama has completed his PhD at the age of 28 years from Tokyo Institute of Technology, and worked as postdoctoral fellow at University of California, Institute of Toxic Substances Research. Now, he teaches Sanitary Engineering for undergraduate course and Ecotoxicology for graduate course as a professor of Department of Civil and Environmental Engineering, Nagoya University. He also serves many governmental committees on environmental pollution, polychlorinated biphenyl remediation, and monitoring of environmental quality.
Research Interest
Design of artificial anaerobic microbial community for bioremediation

Ying MU
Toxicologist
U.S. Food and Drug Administration - Center for Devices and Radiological Health
USA
Biography
Dr. Mu has completed his PhD from Gunma University/Japan and postdoctoral studies at Kyoto University, Carnegie Mellon University and University of Pittsburgh. He is the board certified toxicologist and a researcher at the FDA. He has published more than 25 papers in reputed journals and is interested in the development of biomarkers for allergic risk assessment.
Research Interest
He is interested in the development of biomarkers for allergic risk assessment.